Methoxyflurane for cancer patients with incident pain receiving radiotherapy
Phase 4
Not yet recruiting
- Conditions
- Incident or movement related pain during transportation to and delivery of radiation therapyOther - Pain management
- Registration Number
- ACTRN12606000073505
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Radiotherapy related incident/movement pain; age: ECOG <=2.
Exclusion Criteria
Renal imparirment (>2xnormal); previous toxicity or use of methoxyflurane; family or personal history of hyperthermia or sensitivites to flourinated anaesthetics; patients receiving Patient Controlled Analgesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine if there is a difference in efficacy between methoxyflurane and standard analgesia in controlling pain associated with movement and positioning of cancer patients during a radiotherapy session.[Pain will be measured at several points during the procedure with the primary end-points being 5 minutes before transport to and 5 minutes after completion of, radiotherapy.]
- Secondary Outcome Measures
Name Time Method To determine if there is a difference in efficacy between methoxyflurane and standard analgesia in controlling distress associated with movement and positioning of cancer patients during a radiotherapy session.[Distress Thermometer will measure the patient's perception of distress 30mins and 5 mins before the radiotherapy and again post radiotherapy. Both groups will be measured similarly.]